References
- Raymond E , Chaney SG , Taamma A , Cvitkovic E . Oxaliplatin: A review of preclinical and clinical studies. Ann Oncol. 1998;9:1053–71.
- Malhotra NK , Aslam R , Lipman SP , Bilski VJ . Acute ototoxicity from a single infusion of oxaliplatin. Ear Nose Throat J. 2010 Jun;89:258–61.
- Ibrahim A , Hirschfeld S , Cohen MH , Griebel DJ , Williams GA , Pazdur R . FDA drug approval summaries: oxaliplatin. Oncologist. 2004;9:8–12.
- Vietor NO , George BJ . Oxaliplatin-induced hepatocellular injury and ototoxicity: a review of the literature and report of unusual side effects of a commonly used chemotherapeutic agent. J Oncol Pharm Pract. 2012 Sep;18:355–9.
- Hellberg V , Wallin I , Eriksson S , Hernlund E , Jerremalm E , Berndtsson M , et al. Cisplatin and oxaliplatin toxicity:Importance of cochlear kinetics as a determinant for ototoxicity. J Natl Cancer Inst. 2009;101:37–47.
- Dammeyer P , Hellberg V , Wallin I , Laurell G , Shoshan M , Ehrsson H , et al. Cisplatin and oxaliplatin are toxic to cochlear outer hair cells and both target thioredoxin reductase in organ of Corti cultures. Acta Otolaryngol. 2014 May;134:448–54.
- Reddel R , Kefford R , Grant JM , Coates AS , Fox RM , Tattersall MH . Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration. Cancer Treat Rep. 1982;66:19–23.
- Hijri FZ , Arifi S , Ouattassi N , Mellas N , El Mesbahi O . Oxaliplatin-induced ototoxicity in adjuvant setting for colorectal cancer: unusual side effect. J Gastrointest Cancer. 2014 Mar;45:106–8.
- Oh SY , Wasif N , Garcon MC , Rodriguez G , Saif MW . Ototoxicity associated with oxaliplatin in a patient with pancreatic cancer. JOP. 2013 Nov 10;14:676–9.
- Stachler RJ , Chandrasekar SS , Archer SM , Rosenfeld RM , Schwartz SR , Barrs DM , et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012 Mar;146(3 Suppl):S1–35.